2019
DOI: 10.1371/journal.pone.0217775
|View full text |Cite
|
Sign up to set email alerts
|

Morbidity after surgical management of cervical cancer in low and middle income countries: A systematic review and meta-analysis

Abstract: Objective To investigate morbidity for patients after the primary surgical management of cervical cancer in low and middle-income countries (LMIC). Methods The Pubmed, Cochrane, the Cochrane Central Register of Controlled Trials, Embase, LILACS and CINAHL were searched for published studies from 1 st Jan 2000 to 30 th June 2017 reporting outcomes of surgical management of cervical cancer in LMIC. Random-effects meta-… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
13
0
1

Year Published

2020
2020
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 16 publications
(15 citation statements)
references
References 72 publications
1
13
0
1
Order By: Relevance
“…In our study, LRH and ARH had equivalent survival rates, supporting some previous comparative studies (Díaz-Feijoo et al, 2008;Nam et al, 2012;Cao et al, 2015;Wang et al, 2016). A study compared IA2-IIB 95%: 0.75-0.89) (Allanson et al, 2019). However our mean differences IN OS of 16.3 months, 10.4%, and 2.05 fold, favoring ARH, and our mean differences in DFS of 14,75 months, 12.6%, and 2.13 fold, favoring ARH, could not be negligible.…”
Section: Discussionsupporting
confidence: 90%
See 1 more Smart Citation
“…In our study, LRH and ARH had equivalent survival rates, supporting some previous comparative studies (Díaz-Feijoo et al, 2008;Nam et al, 2012;Cao et al, 2015;Wang et al, 2016). A study compared IA2-IIB 95%: 0.75-0.89) (Allanson et al, 2019). However our mean differences IN OS of 16.3 months, 10.4%, and 2.05 fold, favoring ARH, and our mean differences in DFS of 14,75 months, 12.6%, and 2.13 fold, favoring ARH, could not be negligible.…”
Section: Discussionsupporting
confidence: 90%
“…A population-based study compared 475 LRH patients to 483 ARH patients operated on from 2006 to 2017 with a median follow-up of 6 years, adjusted for patient factors and surgeon volume, concluded that LRH was oncologically safe for IA but not IB tumors (Cusimano et al, 2019). A systematic review of 4731 patients in 17 studies that included only low-and middle-income countries described similar overall and DFS rates for LRH and ARH (Allanson et al, 2019).…”
Section: Introductionmentioning
confidence: 99%
“…Surgery is the mainstay of treatment in early stages. In a systematic review, it was observed that the perioperative acute complications were comparable amongst LMICs and high-income countries [20]. However, reporting of longterm outcomes is suboptimal due to various reasons, including inappropriate selection criteria, availability of adjuvant therapies in high-risk groups and also the common use of neoadjuvant chemotherapy (NACT) prior to surgery in locally advanced stages.…”
Section: Treatment and Outcomesmentioning
confidence: 99%
“…In recent years, minimally invasive surgery such as laparoscopic surgery and robotic surgery has become the main trend in research on surgery for endometrial cancer and cervical cancer 1 . But it is still di cult for developing countries or hospitals without top facilities, and therefore it is necessary to improve the level of surgical technique by laparotomy 2,3,4,5 . Furthermore, because of the denial of the laparoscopic approach compared to the laparotomy for cervical cancer in the LACC trial rea rmed the importance of radical hysterectomy with the laparotomy approach 6 .…”
Section: Introductionmentioning
confidence: 99%